MK

Manish Kumar Srivastava

Active Director Director DIN 10817142
DIN 10817142 First appointment Oct 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Manish Kumar Srivastava

Data last updated:

Manish Kumar Srivastava is a Director at Velomed Healthcare Private Limited (since 2024).

DIN 10817142
Primary Designation Director
First Appointment 22 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Velomed Healthcare Private Limited U46497DL2024PTC438032
Director22 Oct 20242024Active

Board colleagues of Manish Kumar Srivastava

NameDINCompanyDesignation
Apoorv Sinha10919610Velomed Healthcare Private LimitedAdditional Director
Shilpa Verma10817143Velomed Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Velomed Healthcare Private Limited
Premium access

Shareholding and investment profile for Manish Kumar Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manish Kumar Srivastava

Manish Kumar Srivastava currently holds 1 directorship: Velomed Healthcare Private Limited (Director, since 22 Oct 2024).

Manish Kumar Srivastava was first appointed on 22 Oct 2024 as Director at Velomed Healthcare Private Limited.

The current boards of Manish Kumar Srivastava's companies include Apoorv Sinha (Velomed Healthcare Private Limited), Shilpa Verma (Velomed Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available